7ZT-22583-03067
3 vaccinations
3 coded responses
36 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 194 / PA
- Registered
- 2021-04-18
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-18
Registered in v-safe
-
2021-04-18
Dose 1 — Pfizer-BioNTech
- 2021-04-18
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-05-04
- 2021-05-10
-
2021-05-11
Dose 2 — Pfizer-BioNTech
- 2021-05-11
- 2021-05-12
-
2021-05-13
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Fatigue or tirednessAdult check-in
- 2021-05-14
- 2021-05-15
- 2021-05-16
- 2021-05-17
- 2021-05-18
- 2021-05-25
- 2021-06-01
- 2021-06-08
- 2021-06-15
- 2021-06-22
- 2021-08-11
- 2021-11-09
-
2021-12-01
Dose 3 — Pfizer-BioNTech
- 2021-12-01
- 2021-12-02
- 2021-12-03
- 2021-12-04
- 2021-12-07
- 2021-12-15
- 2021-12-22
-
2021-12-29
Survey response — day 28, dose 3MedDRA: Fatigue — Feeling: GoodFree text: FatigueMedDRA releases: 2024-11 · check-in free text available
- 2022-01-05
- 2022-01-12
-
2022-03-04
Survey response — 3 months, dose 3MedDRA: Fatigue, Respiratory tract congestion, Rhinorrhoea — Feeling: Good · Be unable to do your normal daily activitiesFree text: Fatigue, congestion, runny nose.MedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Survey response — 6 months, dose 3MedDRA: Ruptured ectopic pregnancy — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Emergency room or emergency department visitFree text: Ruptured ectopic pregnancyMedDRA releases: 2024-11 · check-in free text available
-
2022-06-01
Report sent to call center — 6 months, dose 3Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare prEmergency room or emergency department visit · 1 call case(s)
- 2022-06-02
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-18 | Pfizer-BioNTech | |
| 2 | 2021-05-11 | Pfizer-BioNTech | |
| 3 | 2021-12-01 | Pfizer-BioNTech | No |
Call center
| Reported | Outcome | VAERS-related outcome |
|---|---|---|
| 2022-06-01 | Unsuccessful |
Free text
Release 10 — day 28, dose 3
Symptoms: Fatigue
Release 11 — 3 months, dose 3
Symptoms: Fatigue, congestion, runny nose.
Release 11 — 6 months, dose 3
Symptoms: Ruptured ectopic pregnancy
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Fatigue | · | · | ✓ |
| SD | Respiratory tract congestion | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Ruptured ectopic pregnancy | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release